Trader Note — 9342 total
Enphase Energy enters the July 28 earnings window with its most meaningful short-covering wave in months, even as the stock sits 28% below where it traded in May. The short-covering story is the defining feature of the…
Fortune Brands Innovations enters the week of June 30 having just completed one of its sharpest short-term recoveries in recent memory — a 35% gain in five days that puts the stock at $54.90, and the central question…
Prologis heads into its July 16 earnings date nursing a 6.7% weekly loss — the sharpest one-week selloff in recent months — while analyst opinion splits more visibly than it has all quarter. The analyst community is…
Nebius Group has recovered sharply from last week's selloff, closing Tuesday at $276.17 — up 5.75% on the day and nearly flat on the week — yet the short position has barely moved, the borrow pool remains almost…
FYC, the First Trust Small Cap Growth AlphaDEX Fund, heads into July with an unusual split: short sellers have been cutting positions aggressively while the cost to borrow their remaining stake stays stubbornly…
Huntington Ingalls Industries heads into its July 30 earnings report with short sellers cutting positions aggressively while options traders are becoming meaningfully more defensive — a split that defines the week's…
Meta Platforms has found its footing after weeks of erosion, closing at $563.29 on June 30 — up roughly $13 from the $550.25 trough documented in Sunday's stock report — but the stock remains 32% below the Street's…
Pacira BioSciences heads into its July 31 earnings report with a notable gap opening between a still-heavy short position and a stock that has quietly put together its best month in some time. The short interest story…
STAG Industrial heads into its July 29 earnings with short sellers adding positions at the fastest weekly pace in over a month, even as the borrow market remains far from strained. The most notable move in the data…
Booz Allen Hamilton arrives at the final session of June with a month-long slide that has carried the stock down 23% to $60.67 — and the Street is still cutting targets rather than defending the name. The most…
REMX, VanEck's rare earth and strategic metals ETF, enters July with a sharply divided signal: shorts have retreated meaningfully from June highs, yet the fund itself has lost ground on the week — a divergence worth…
GNR, the SPDR S&P Global Natural Resources ETF, ends June with a modest stabilisation — and the two most striking positioning shifts of the past week both point in the same direction. A week ago, the story here was a…
Tesla closes out June with its best weekly gain in months, yet a freshly confirmed Q2 delivery miss and Elon Musk's $7 billion share sale hang over the setup heading into July 22 earnings. The price reversal this week…
COPX, the Global X Copper Miners ETF, enters July with a notable split: short sellers are covering aggressively even as the fund itself posts a bruising monthly loss. The most striking move this week is the pace of…
CorMedix heads into July with a stubborn short base, a stock down nearly 9% on the week, and an August earnings date that is moving from background noise to front-of-mind. The short side of the ledger is the defining…
LyondellBasell enters July under heavy selling pressure, down 21% in a single month to $52.65, with short sellers accelerating bets against it and the Street cutting targets across the board. The most striking…
General Motors has now slipped another 2.4% on the week to $77.08, extending the retreat from Mary Barra's $85 sell cluster into a roughly $8 gap — and with earnings three weeks out, that gap is becoming the defining…
STNG heads into July with a fresh analyst downgrade compounding a sector-wide selloff, leaving the stock down 15% on the week and facing its first bearish call from a bank that was bullish just seven weeks ago. The…
TQQQ enters July with rare momentum behind it — the 3x leveraged Nasdaq-100 ETF posted a 9% weekly gain and a 5% single-day move on June 30, while short sellers quietly unwound positions through the rally. The most…
EyePoint Pharmaceuticals heads into July with a sharp analyst upgrade colliding against a short base that refuses to budge — a tension that defines the stock's setup heading into its July 31 earnings event. The most…
